Nilutamide
ATC Code
L02BB02
Nilutamide
Definition
A synthetic, nonsteroidal agent with antiandrogenic properties. Nilutamide preferentially binds to androgen receptors and blocks androgen receptor activation by testosterone and other androgens; this agent may inhibit androgen-dependent growth of normal and neoplastic prostate cells. (NCI04)
Also known as 1-(3'-Trifluoromethyl-4'-nitrophenyl)-4,4-dimethylimidazoline-3,5-dione, 5,5-Dimethyl-3-[4-nitro-3-(trifluoro-methyl)phenyl]-2,4-imidazolidinedione, Anandron, Nilandron, NILUTAMIDE, RU-23908 — per NCIT
Also identified as
- ATC L02BB02 per RXNORM
- NCIT NCIT:C1173 per NCIT
- SCTID 404866003 per RXNORM
- SCTID 96372005 per RXNORM
- UNII 51G6I8B902 per RXNORM
Indications
| Disease | Relation | Source |
|---|---|---|
| Carcinoma | may treat | MEDRT · Public domain (U.S. Government work) |
| Prostate cancer | may treat | MEDRT · Public domain (U.S. Government work) |